2021 House Bill 4351 ↩

Senate Roll Call 30: Passed

To impose new rules, restrictions and disclosure requirements on health insurers and pharmacy benefit managers selling and marketing prescription drugs to hospitals and clinics that federal rules make eligible for discounts due to treating above-average numbers of Medicaid patients. These providers are not required to pass the savings along to patients. Among other changes the bill would prohibit insurers from requiring patient co-payments for a drug that are higher than the medical provider's cost.